7. De Rosa SC, Herzenberg LA, Herzenberg LA,
Roederer M. 11-color, 13-parameter flow cytom-
etry: identification of human naive T cells by phe-
notype, function, and T-cell receptor diversity. Nat
Med. 2001;7:245-248.
8. Wherry EJ, Teichgraber V, Becker TC, et al. Lin-
eage relationship and protective immunity of
memory CD8 T cell subsets. Nat Immunol. 2003;
4:225-234.
9. Ramilo O, Bell KD, Uhr JW, Vitetta ES. Role of
CD25ϩ and CD25-T cells in acute HIV infection
in vitro. J Immunol. 1993;150:5202-5208.
10. Zhang Z, Schuler T, Zupancic M, et al. Sexual
transmission and propagation of SIV and HIV in
resting and activated CD4ϩ T cells. Science.
1999;286:1353-1357.
11. Stevenson M, Stanwick TL, Dempsey MP, Lam-
onica CA. HIV-1 replication is controlled at the
level of T cell activation and proviral integration.
EMBO J. 1990;9:1551-1560.
12. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip
A, Chen IS. HIV-1 entry into quiescent primary
lymphocytes: molecular analysis reveals a labile,
latent viral structure. Cell. 1990;61:213-222.
13. Grossman Z, Meier-Schellersheim M, Sousa AE,
Victorino RM, Paul WE. CD4ϩ T-cell depletion in
HIV infection: are we closer to understanding the
cause? Nat Med. 2002;8:319-323.
14. Grossman Z, Meier-Schellersheim M, Paul WE,
Picker LJ. Pathogenesis of HIV infection: what
the virus spares is as important as what it de-
stroys. Nat Med. 2006;12:289-295.
15. Biancotto A, Grivel JC, Iglehart SJ, et al. Abnor-
mal activation and cytokine spectra in lymph
nodes of people chronically infected with HIV-1.
Blood. 2007;109:4272-4279.
16. Glushakova S, Baibakov B, Margolis LB, Zimmer-
berg J. Infection of human tonsil histocultures: a
model for HIV pathogenesis. Nat Med. 1995;1:
1320-1322.
17. Glushakova S, Baibakov B, Zimmerberg J, Mar-
golis LB. Experimental HIV infection of human
lymphoid tissue: correlation of CD4ϩ T-cell
depletion and virus syncytium-inducing/non-
syncytium-inducing phenotype in histocultures
inoculated with laboratory strains and patient iso-
lates of HIV type 1. AIDS Res Hum Retroviruses.
1997;13:461-471.
18. Wang JK, Kiyokawa E, Verdin E, Trono D. The
Nef protein of HIV-1 associates with rafts and
primes T cells for activation. Proc Natl Acad Sci
U S A. 2000;97:394-399.
19. Gondois-Rey F, Grivel JC, Biancotto A, et al. Seg-
regation of R5 and X4 HIV-1 variants to memory
T cell subsets differentially expressing CD62L in
ex vivo infected human lymphoid tissue. AIDS.
2002;16:1245-1249.
20. Grivel JC, Margolis LB. CCR5- and CXCR4-tropic
HIV-1 are equally cytopathic for their T-cell tar-
gets in human lymphoid tissue. Nat Med. 1999;5:
344-346.
21. Taylor-Fishwick DA, Siegel JN. Raf-1 provides a
dominant but not exclusive signal for the induc-
tion of CD69 expression on T cells. Eur J Immu-
nol. 1995;25:3215-3221.
22. Ziegler SF, Ramsdell F, Alderson MR. The activa-
tion antigen CD69. Stem Cells. 1994;12:456-465.
23. Cotner T, Williams JM, Christenson L, Shapiro
HM, Strom TB, Strominger J. Simultaneous flow
cytometric analysis of human T cell activation an-
tigen expression and DNA content. J Exp Med.
1983;157:461-472.
24. Hara T, Jung LK, Bjorndahl JM, Fu SM. Human
T cell activation: III. Rapid induction of a phos-
phorylated 28 kD/32 kD disulfide-linked early acti-
vation antigen (EA 1) by 12-o-tetradecanoyl
phorbol-13-acetate, mitogens, and antigens. J
Exp Med. 1986;164:1988-2005.
25. Ascher MS, Sheppard HW. AIDS as immune system
activation: II. The panergic imnesia hypothesis. J
Acquir Immune Defic Syndr. 1990;3:177-191.
26. Grossman Z, Herberman RB. T-cell homeostasis
in HIV infection is neither failing nor blind: modi-
fied cell counts reflect an adaptive response of
the host. Nat Med. 1997;3:486-490.
27. Bentwich Z, Kalinkovich A, Weisman Z, Gross-
man Z. Immune activation in the context of HIV
infection. Clin Exp Immunol. 1998;111:1-2.
28. Hazenberg MD, Stuart JW, Otto SA, et al. T-cell
division in human immunodeficiency virus (HIV)-1
infection is mainly due to immune activation: a
longitudinal analysis in patients before and during
highly active antiretroviral therapy (HAART).
Blood. 2000;95:249-255.
29. McCune JM. The dynamics of CD4 ϩ T-cell deple-
tion in HIV disease. Nature. 2001;410:974-979.
30. Silvestri G, Feinberg MB. Turnover of lympho-
cytes and conceptual paradigms in HIV infection.
J Clin Invest. 2003;112:821-824.
31. Sieg SF, Rodriguez B, Asaad R, Jiang W, Bazdar
DA, Lederman MM. Peripheral S-phase T cells in
HIV disease have a central memory phenotype
and rarely have evidence of recent T cell receptor
engagement. J Infect Dis. 2005;192:62-70.
32. Kovacs JA, Lempicki RA, Sidorov IA, et al. Identi-
fication of dynamically distinct subpopulations of
T lymphocytes that are differentially affected by
HIV. J Exp Med. 2001;194:1731-1741.
33. Lempicki RA, Kovacs JA, Baseler MW, et al. Im-
pact of HIV-1 infection and highly active antiretro-
viral therapy on the kinetics of CD4ϩ and CD8ϩ
T cell turnover in HIV–infected patients. Proc Natl
Acad Sci U S A. 2000;97:13778-13783.
34. Glushakova S, Grivel JC, Fitzgerald W, Sylwester A,
Zimmerberg J, Margolis LB. Evidence for the HIV-1
phenotype switch as a causal factor in acquired im-
munodeficiency. Nat Med. 1998;4:346-349.
35. Glushakova S, Grivel JC, Suryanarayana K, et al.
Nef enhances human immunodeficiency virus
replication and responsiveness to interleukin-2 in
human lymphoid tissue ex vivo. J Virol. 1999;73:
3968-3974.
36. Malkevitch N, McDermott DH, Yi Y, et al. Core-
ceptor choice and T-cell depletion by R5, X4, and
R5X4 HIV-1 variants in CCR5-deficient
(CCR5delta32) and normal human lymphoid tis-
sue. Virology. 2001;281:239-247.
37. Eckstein DA, Penn ML, Korin YD, et al. HIV-1 ac-
tively replicates in naive CD4(ϩ) T cells residing
within human lymphoid tissues. Immunity. 2001;
15:671-682.
38. Penn ML, Grivel JC, Schramm B, Goldsmith MA,
Margolis L. CXCR4 utilization is sufficient to trig-
ger CD4ϩ T-cell depletion in HIV-1–infected hu-
man lymphoid tissue. Proc Natl Acad Sci U S A.
1999;96:663-668.
39. Grivel JC, Penn ML, Eckstein DA, et al. Human
immunodeficiency virus type 1 coreceptor prefer-
ences determine target T-cell depletion and cellu-
lar tropism in human lymphoid tissue. J Virol.
2000;74:5347-5351.
40. Morgan CD, Greene JF Jr, Measel JW Jr. Induc-
tion of surface antigen CD69 expression in
T-lymphocytes following exposure to actinomycin
D. Int J Immunopharmacol. 1999;21:689-703.
41. Amlot PL, Tahami F, Chinn D, Rawlings E. Activa-
tion antigen expression on human T cells: I. Anal-
ysis by two-colour flow cytometry of umbilical
cord blood, adult blood and lymphoid tissue. Clin
Exp Immunol. 1996;105:176-182.
42. Shiow LR, Rosen DB, Brdickova N, et al. CD69
acts downstream of interferon-alpha/beta to in-
hibit S1P1 and lymphocyte egress from lymphoid
organs. Nature. 2006;440:540-544.
43. Swingler S, Mann A, Jacque J, et al. HIV-1 Nef
mediates lymphocyte chemotaxis and activation
by infected macrophages. Nat Med. 1999;5:997-
1003.
44. Manninen A, Renkema GH, Saksela K. Synergis-
tic activation of NFAT by HIV-1 nef and the Ras/
MAPK pathway. J Biol Chem. 2000;275:16513-
16517.
45. Ameisen JC, Capron A. Cell dysfunction and
depletion in AIDS: the programmed cell death
hypothesis. Immunol Today. 1991;12:102-105.
46. Terai C, Kornbluth RS, Pauza CD, Richman DD,
Carson DA. Apoptosis as a mechanism of cell
death in cultured T lymphoblasts acutely infected
with HIV-1. J Clin Invest. 1991;87:1710-1715.
47. Laurent-Crawford AG, Krust B, Muller S, et al.
The cytopathic effect of HIV is associated with
apoptosis. Virology. 1991;185:829-839.
48. Gougeon ML, Laurent-Crawford AG, Hovanes-
sian AG, Montagnier L. Direct and indirect
mechanisms mediating apoptosis during HIV in-
fection: contribution to in vivo CD4 T-cell deple-
tion. Semin Immunol. 1993;5:187-194.
49. Meyaard L, Otto SA, Keet IP, Roos MT, Miedema
F. Programmed death of T cells in human immu-
nodeficiency virus infection: no correlation with
progression to disease. J Clin Invest. 1994;93:
982-988.
50. Gougeon ML, Ledru E, Lecoeur H, Garcia S.
T cell apoptosis in HIV infection: mechanisms and
relevance for AIDS pathogenesis. Results Probl
Cell Differ. 1998;24:233-248.
51. Koester SK, Roth P, Mikulka WR, Schlossman
SF, Zhang C, Bolton WE. Monitoring early cellular
responses in apoptosis is aided by the mitochon-
drial membrane protein-specific monoclonal anti-
body APO2.7. Cytometry. 1997;29:306-312.
52. Me´ tivier D, Dallaporta B, Zamzami N, et al.
Cytofluorometric detection of mitochondrial alter-
ations in early CD95/Fas/APO-1-triggered apo-
ptosis of Jurkat T lymphoma cells: comparison of
7 mitochondrion-specific fluorochromes. Immunol
Lett. 1998;61:157-163.
53. Muro-Cacho CA, Pantaleo G, Fauci AS. Analysis
of apoptosis in lymph nodes of HIV–infected per-
sons: intensity of apoptosis correlates with the
general state of activation of the lymphoid tissue
and not with stage of disease or viral burden.
J Immunol. 1995;154:5555-5566.
704 BIANCOTTO et al BLOOD, 15 JANUARY 2008
⅐
VOLUME 111, NUMBER 2
For personal use only. at CAPES Usage on February 7, 2008. www.bloodjournal.orgFrom